Growth Hormone Upregulates Melanocyte-Inducing Transcription Factor Expression and Activity via JAK2-STAT5 and SRC Signaling in GH Receptor-Positive Human Melanoma

Growth hormone (GH) facilitates therapy resistance in the cancers of breast, colon, endometrium, and melanoma. The GH-stimulated pathways responsible for this resistance were identified as suppression of apoptosis, induction of epithelial-to-mesenchymal transition (EMT), and upregulated drug efflux...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Reetobrata, Kulkarni, Prateek, Qian, Yanrong, Walsh, Christopher, Arora, Pranay, Davis, Emily, Duran-Ortiz, Silvana, Funk, Kevin, Ibarra, Diego, Kruse, Colin, Mathes, Samuel, McHugh, Todd, Brittain, Alison, Berryman, Darlene E., List, Edward O., Okada, Shigeru, Kopchick, John J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769493/
https://www.ncbi.nlm.nih.gov/pubmed/31547367
http://dx.doi.org/10.3390/cancers11091352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769493/
https://www.ncbi.nlm.nih.gov/pubmed/31547367
http://dx.doi.org/10.3390/cancers11091352

Ejemplares similares